Académique Documents
Professionnel Documents
Culture Documents
11/20/2012
INTRODUCTION
DHF relatively new diseases in Indonesia 1968 in Surabaya and Jakarta 1973 in Manado Management divided in DHF and DSS Mortality rate in : 1968 41.3 % 1992 2.9 % 1995 2.5 %
2
11/20/2012
Laboratoric
Thrombocytopenia Hemoconcentration
11/20/2012
I II III IV
: : : :
Fever + non spesific + RL (+) I + Other hemorrh manifest II + mild shock III + severe shock
11/20/2012
Crisis days III > IVFD 12 24 hours PCV , Tr < 50 000 Health center / >
11/20/2012
Fever phase
Oral fluid : 50 ml/kgBW for 4 6 hours IVFD manitenance : 80 100 ml/kg/days Antipyretic : paracetamol 10 mg/kgBW/time Convulsion : Phenobarbital 5 mg/kgBW/days Critical Ill : Days 3 - 5
11/20/2012
Temperature leakage Reconvalescen reabsorbtion of fluid Sign + symptom of shock hospitalization Fluid Recommended (WHO)
Cristaloid Colloid
: RL RL-D5% RA RA-D5% NaCl 0.9 % - NaCl 0.9%-D5% : Plasma Dextran L 40 HAES Gelofusin Gelofundin
10
11/20/2012
DSS Shock emergency fluid recovery 48 hours Replacement of plasma volume Cristaloid : 20 ml/kgBW/30 min Still Shock : Koloid 10 20 ml/kgBW/h Maximal 30 ml/kgBW Improvement : Cristaloid 10 20 ml/kgBW/h Still syok, PCV bleeding blood PCV > 40 blood 10 ml/kgBW/h Massive bleeding blood 20 ml/kgBW/h Improvement Cristaloid
11/20/2012
11
Tourniquet (+)
Tourniquet (-)
Hospitalization
Ambulatory
12
Improvement
Evaluation 12 24 h
Improvement
3 ml/kgBW/h
IVFD Stop (24 48 h) If Vital Sign / PCV / Diuresis stable
11/20/2012
PCV
DHF Gr IV
Shock (-)
Shock (+) Decrese consiousness Weak pulse / not palpable BP < 20 mmHg RDS / Cyanosis (+) Cold Extremities Diuresis < 1 ml/kgBW/h Examine Glood Sugar
Improvement consiousness Strong pulse BP > 20 mmHg No RDS / Cyanosis Warm Extremities Diuresis > 1 ml/kgBW/h
Reduce IVFD (10ml/kgBW/h) Strict Evaluation Vital sign Bleeding sign Diuresis Hb, PCV, Tr Stable max 24 h 5 ml/kgBW/h PCV Fresh WB 10 ml/kgBW Can repeated IVFD stop 48 h Shock (-)
Shock (+)
IVFD (15 -20 ml/kgBW/h) Koloid / Plasma (10-20 max 30 ml/kgBw/h Correction accidosis Evaluation 1 h
3 ml/kgBW/h
11/20/2012
14
COMPLICATIONS
Electrolyte Imbalance
Hyponatremia Hypocalcemia Early IVFD Hypotonic Solution Not IVFD Not Use Colloidal Sol / Plasma Not Give blood transf Not Calculate IVFD
15
Fluid overload
11/20/2012
COMPLICATIONS
Signs and Symptoms of Fluid Overload RSD, Dyspnea and Tachypnea Massive acites Rapid Pulse Pulse pressure Crepitation/Ronchi Porr tissue perfusion
11/20/2012 16
COMPLICATIONS
Management of fluid overload Change IV to Dextrans 40 Urinary Catheter Furosemide 1 mg/kgBW, IV Still Shock Dextrans 40, 10 mg/kgBW in 10-15 min Record Urine output Furosemide may repeat if still RDS CVP if not Response furosemide Ventilatory support Pleural/peritoneal tapping
11/20/2012 17
COMPLICATIONS
Unusual manifestation of DHF Less than 5% of patient Encephalopathy/encephalitis Hepatic failure Renal failure Dual infections Underlying conditions
11/20/2012 18
COMPLICATIONS
Signs and Symptoms of Fluid Overload Prolonged shock Acute hemolysis + Hb uria
G6PD Hemoglobinopathy Transfussion PRC of FWB IVFD according the stage Alkaline urine
19
11/20/2012
COMPLICATIONS
Dual Infections Associate : GI, Salmonella RI, Pneumonia Urinary infections Skin + soft tissue inf Nosocomial Thrombophlebitis Pneumonia UTI (Catheter) Others Transfussion reaction Hepatitis Massive GI Hem Drugs reactions
11/20/2012 20
COMPLICATIONS
11/20/2012
COMPLICATIONS Management of DHF hepatic encephalopathy Maintain oxygenation Prevent intracranial press :
11/20/2012
Amonia production Vit K1 3-10 mg IV Correct metab acidosis PRC if indicated Antibiotic H2 Blocker if massive GI Bleeding Avoid unnecessary drugs Exchange tranf if needed Dyalisis if needed Branch chain aminoacid
22
Not fever in 24 h Good appetite Good general condition Diuresis Normal PCV (38 40) 2 days after shock No dyspnea Platelet > 50 000/mm3 No complication
23
11/20/2012
CAUSES OF DEATH
11/20/2012
24
11/20/2012
25